News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Artimplant Year-End Report January – December 2009
February 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: Artimplant (STO:ARTIB)
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Pfizer and Indivior Trim Workforces, Seeking Productivity Gains
August 28, 2025
·
193 min read
·
BioSpace Editorial Staff
Special edition
Deep Dive: Women in Biopharma
August 27, 2025
·
1 min read
·
Annalee Armstrong
Rare diseases
Amylyx Axes Drug Program for Rare Neurodegenerative Disorder
August 27, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
Novartis, BioArctic Partner To Penetrate the Blood-Brain Barrier
August 27, 2025
·
1 min read
·
Tristan Manalac
